VTYX FY 2023 Earnings — Ventyx Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

VTYXVentyx Biosciences, Inc.

$1B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$208M

Net Income

-$193M

EPS (Diluted)

$-3.30

Cash Flow

Operating Cash Flow

-$167M

Free Cash Flow

-$167M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$278M

Total Liabilities

$34M

Stockholders' Equity

$244M

Cash & Equivalents

$52M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$208M	-$113M	-83.8%
Net Income	-$193M	-$108M	-78.0%